Union Minister of Science and Technology Jitendra Singh has launched India’s first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer.
Vaccine name: CERVAVAC
DCGI had granted market authorisation to Serum Institute of India to manufacture an indigenously-developed vaccine against cervical cancer.
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
